Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Patent
1997-04-28
1998-12-01
Tsang, Cecilia J.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
530324, 530325, 514 12, 514 13, 514 14, A61K 3810
Patent
active
058440771
ABSTRACT:
A method for producing analgesia or for neuroprotection in a mammal comprising administering a therapeutically effective amount of a conantokin to the mammal.
REFERENCES:
patent: 5364842 (1994-11-01), Justice
patent: 5432155 (1995-07-01), Olivera
patent: 5523323 (1996-06-01), Maccecchini
patent: 5587454 (1996-12-01), Justice
Skolnick et al., "Conotoxin-G and its Analogs", Chapter 11, pp. 155-165, in Direct and Allosteric Control of Glutamate Receptors, Palfreyman et al., CRC Press, 1994.
Advokat et al., Brain Research, 641, 135-140 (1994).
Anson et al., Letters to Nature, vol. 315, 683-685 (1985).
Berg et al., Experimental Cell Research, 192, 32-40 (1991).
Carter et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 253, No. 2, 275-482 (1990).
Chandler et al., The Journal of Biological Chemistry, vol. 268 No. 23, 17173-17178 (1993).
Coderre, APS Journal, vol. 3, No. 4, 232-239 (1994).
Coderre, European Journal of Neuroscience, vol. 5, 390-393 (1993).
Coderre, Pain, 59, 353-359 (1994).
Coderre, European Journal of Neuroscience, vol. 5, 390-393 (1993).
Dickenson et al., Gen. Pharmac., vol. 28, No. 5, 633-638 (1997).
Dickson et al., Trends in Pharmacological Sciences, vol. III, 307-309 (1990).
Elliott et al., Pain, 59, 361-368 (1994).
Felby et al, Pain, 64, 283-291, (1995).
Feng et al., Pain, 66, 343-349 (1996).
Furuyama et al., Molecular Brain Research, 18, 141-151 (1993).
Haack et al., Neuroscience Letters, 163, 63-66 (1993).
Hammerland et al., European Journal of Pharmacology-Molecular Pharm. Section, 226, 239-244 (1992).
Hao et al., Pain, 66, 279-285 (1996).
Henry et al., APS Journal, 3 (4) , 249-256 (1994).
Hoffman et al., Neuropharmacology and Neurotoxicology, vol. 7, No. 3, 838-840 (1996).
Hunter et al., Neuroscience Letters, 174, 217-221 (1994).
Malmberg et al., Pain, 291-300 (1993).
McIntosh et al, The Journal of Biological Chemistry, vol. 259, No. 23, 114343-114346 (1984).
Mena et al., Neuroscience Letters, 118, 241-244 (1990).
Michaelis, Neural Notes, vol.II, 2, 3-7 (1996).
Millan et al., Neuroscience Letters, 178, 139-143 (1994).
Murray et al., Pain, 44, 179-185 (1991).
Nasstrom et al., European Journal of Pharmacology, 212, 21-29 (1992).
Nikolajsen et al., Pain, 67, 69-77 (1996).
Perrault, et al., European Journal of Pharmacology, 183, 942 (1990).
Skolnick et al., Journal of Neurochemistry, vol. 59, No. 4, 1516-1521 (1992).
Steinberg et al., Journal Neurosurg., 84, 860-866 (1996).
Vaccarino et al., Brain Research, 615, 331-334 (1993).
Walls et al., Brain Research, 670, 342-346 (1995).
Xu et al., Gene, 81, 139-149 (1989).
Zhou et al, Neurosci., "Synthetic Conantokins: Novel Polyamine Antagonists of the NMDA Receptor Complex", (1996).
Skolnick, J. Neurochem 59, 1516, 1992.
Chandler, J. Biol. Chem, 268, 17173, 1993.
Dickenson, Trends in Pharmacol Sci., 11, 307, 1990.
Cytotherapeutics, Inc.
Elrifi Ivor R.
Levin Mintz
Lukton David
Tsang Cecilia J.
LandOfFree
Use of conantokins for producing analgesia or for neuroprotectio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of conantokins for producing analgesia or for neuroprotectio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of conantokins for producing analgesia or for neuroprotectio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396563